ARVEE
Start SIP
Invest Now
Start SIP in ARVEE
Performance
- Low
- ₹161
- High
- ₹163
- 52 Week Low
- ₹127
- 52 Week High
- ₹233
- Open Price₹163
- Previous Close₹162
- Volume532
Investment Returns
- Over 1 Month -0.23%
- Over 3 Month -5.78%
- Over 6 Month + 7.26%
- Over 1 Year -5.56%
Smart Investing Starts Here Start SIP with Arvee Laboratories (India) for Steady Growth!
Arvee Laboratories (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 129.2
- PEG Ratio
- -14.7
- Market Cap Cr
- 178
- P/B Ratio
- 5.7
- Average True Range
- 6.9
- EPS
- 1.25
- Dividend Yield
- 0
- MACD Signal
- -0.81
- RSI
- 48.39
- MFI
- 43.69
Arvee Laboratories (India) Financials
Arvee Laboratories (India) Technicals
EMA & SMA
Current Price
₹161.10
-1.35
(-0.83%)
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹161.75
- 50 Day
- ₹163.45
- 100 Day
- ₹164.60
- 200 Day
- ₹164.85
Resistance and Support
161.82
- R3 164.70
- R2 163.98
- R1 162.54
- S1 160.38
- S2 159.66
- S3 158.22
Arvee Laboratories (India) Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-08-12 | Quarterly Results | |
| 2025-05-09 | Audited Results & Others | To consider Other business matters. |
| 2025-02-12 | Quarterly Results | |
| 2024-11-14 | Quarterly Results & Others | To consider other business matters. |
| 2024-08-13 | Quarterly Results |
Arvee Laboratories (India) F&O
About Arvee Laboratories (India)
- NSE Symbol
- ARVEE
- BSE Symbol
- Managing Director
- Mr. Shalin Sudhakarbhai Patel
- ISIN
- INE006Z01016
Similar Stocks to Arvee Laboratories (India)
Arvee Laboratories (India) FAQs
Arvee Laboratories (India) share price is ₹161 As on 11 November, 2025 | 21:53
The Market Cap of Arvee Laboratories (India) is ₹177.5 Cr As on 11 November, 2025 | 21:53
The P/E ratio of Arvee Laboratories (India) is 129.2 As on 11 November, 2025 | 21:53
The PB ratio of Arvee Laboratories (India) is 5.7 As on 11 November, 2025 | 21:53
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.